Search The Medical Knowledge Base
Drug Details
Xylometazoline Nasal Drops
- Drug Class Description
Sympathomimetics (decongestants). - Generic Name
Generic - Presentation
Nasal drops, solution The product is a clear, colourless solution - Description
Xylometazoline Hydrochloride 0.1% w/v - Indications
For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever), sinusitis - Adult Dosage
Adults and elderly (all indications): 2 or 3 drops in each nostril 2 or 3 times daily.
The drops are suitable for children over 12 years of age.
Route of administration: Nasal use
- Child Dosage
Under three months, not recommended; under two years, recommended; under two years, doctor's advice only; over three months, instil one to two drops into each nostril once or twice daily when required. Maximum duration, seven days. - Contra Indications
Known hypersensitivity to Otrivine.
Patients with trans-sphenoidal hypophysectomy or surgery exposing the dura mater.
- Special Precautions
Patients are advised not to take decongestants for more than seven consecutive days. Otrivine, like other preparations belonging to the same class of active substances, should be used only with caution in patients showing a strong reaction to sympathomimetic agents as evidenced by signs of insomnia, dizziness etc.
- Do not exceed the recommended dosage
- Decongestants should not be used for more than seven consecutive days. If symptoms persist consult your doctor
- If you are pregnant or taking other medicines or are under a doctor's care consult him before using Otrivine
- The adult drops should not be used for infants or children under 12 years
- Each Otrivine pack should be used by one person only to prevent any cross infection
- Some patients who have sensitive nasal passages may feel some local discomfort when applying nasal drops. Other side effects are very rare
- Keep medicines out of reach of children
- Adverse Drug Reactions
The following side effects have occasionally been encountered: A burning sensation in the nose and throat, local irritation, nausea, headache, and dryness of the nasal mucosa.
Systemic cardiovascular effects have occurred, and this should be kept in mind when giving Otrivine to people with cardiovascular disease